Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 8710

Original article / research
Year : 2017 | Month : January | Volume : 11 | Issue : 1 | Page : BC01 - BC04

Unusual Dyslipidemia in Patients with Chronic Kidney Diseases

Rashmi Rekha Phukan, Rohini K Goswami

Dr. Rashmi Rekha Phukan, Padum Nagar 2, Opposite Public High School, Dibrugarh-786001, Assam, India. E-mail: drrashmiphukan@gmail.com

Correspondence Address :
Dr. Rashmi Rekha Phukan,
Padum Nagar 2, Opposite Public High School, Dibrugarh-786001, Assam, India.
E-mail: drrashmiphukan@gmail.com

Abstract

Introduction: Chronic Kidney Disease (CKD) is a major and globally increasing health problem in the general population arising from a spectrum of diseases. Majority of the patients die even before reaching End Stage Renal Disease (ESRD) due to cardiovascular complications which arise due to altered lipoprotein compositions.

Aim: Present study was aimed at evaluating the serum lipid profile in CKD patients and to find the pattern of its alteration in both haemodialyzed and conservatively treated CKD patients.

Materials and Methods: Seventy one randomly selected CKD patients attending a tertiary care hospital of Assam during one year of time frame (40 haemodialyzed and 31 conservatively treated) along with 50 apparently healthy controls were included in the study. Test for serum lipid profile, urea creatinine, FBS, PPBS, total protein and albumin were carried out in all the cases and controls. The results were analyzed and compared with the controls using Microsoft Excel software.

Results: Triglyceride Level (TGL) of CKD group 157.88±61.82, controls 96.98±37.52, Very Low Density Lipoprotein (VLDL) of CKD group 31.58±12.36, controls 19.39±7.50 was marginally elevated and High Density Lipoprotein (HDL) of CKD group 33.40±9.06, controls 45.95±10.35 was significantly reduced in the patient group as compared to the controls and the results were statistically highly significant with p-value<0.001. Total cholesterol (CKD group 128.2±53.57, controls 142.53±31.44) and LDL (CKD group 63.23±46.47, controls 77.35±26.81) were lower in the patient group as compared to the controls, however the difference was statistically not significant (p value 0.09 and 0.059 respectively). There was no statistically significant difference of lipid profile between hemodialyzed and conservatively treated ckd groups and there was no gender related variation of lipid profile too.

Conclusion: Increased TGL and reduced HDL, rather than increased total cholesterol and increased LDL are responsible for the high incidence of cardiovascular complications in CKD patients. Hypolipidemic drugs and low fat diet may be helpful in impeding the progression of cardiovascular complications and decrease mortality and morbidity in those patients.

Keywords

Cardiovascular complications, Dyslipidemia, Haemodialysis, Hypertriglyceridemia

How to cite this article :

Rashmi Rekha Phukan, Rohini K Goswami. UNUSUAL DYSLIPIDEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASES. Journal of Clinical and Diagnostic Research [serial online] 2017 January [cited: 2017 Mar 30 ]; 11:BC01-BC04. Available from
http://jcdr.net/back_issues.asp?issn=0973-709x&year=2017&month=January&volume=11&issue=1&page=BC01-BC04&id=9220

DOI and Others

DOI: 10.7860/JCDR/2017/24172.9220

Date of Submission: Sep 16, 2016
Date of Peer Review: Nov 08, 2016
Date of Acceptance: Nov 28, 2016
Date of Publishing: Jan 01, 2017

Financial OR OTHER COMPETING INTERESTS: None.

JCDR is now Monthly and more widely Indexed .
  • PubMed Central® (PMC)New
  • Academic Search Complete Database
  • Chemical Abstracts Service
  • Directory of Open Access Journals (DOAJ)
  • EBSCOhostNew
  • Embase & EMbiology
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Open J-Gate
  • Popline (reproductive health literature)
  • SCOPUS
  • www.omnimedicalsearch.com